WHO ICTRP trial
ENavogliflozin DElivering Alleviation of Ventricular diastolic dysfunction in…
KCT0009434 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0009434 |
|---|---|
| Public title | ENavogliflozin DElivering Alleviation of Ventricular diastolic dysfunction in nonObstRuctive Hypertrophic CardioMyopathy |
| Scientific title | ENavogliflozin DElivering Alleviation of Ventricular diastolic dysfunction in nonObstRuctive Hypertrophic CardioMyopathy: a prospective, multicenter, randomized, double-blind, placebo-controlled study (ENDEAVOR-HCM) |
| Primary sponsor | Yonsei University Health System, Severance Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase4 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the circulatory system |
| Interventions | Drug : A total of 200 patients will be included, and patients who meet the study subject selection and exclusion criteria will be randomly assigned to a group receiving oral enavogliflozin 0.3 mg once a day or a placebo group taking… |
| Registration date | May 16, 2024 |
| Target size | 200 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: